Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clémentine Sarkozy

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Expert Review of Hematology|November 14, 2013
Treatment approaches to asymptomatic follicular lymphomaClémentine Sarkozy, Gilles Salles
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2013
Diffuse large B-cell lymphoma in the elderly: a review of potential difficultiesClémentine Sarkozy, Bertrand Coiffier
Presse Medicale (Paris, France : 1983)|August 27, 2019
Clémentine Sarkozy, Gilles Salles
Current Opinion in Oncology|August 11, 2015
Primary refractory diffuse large B cell lymphoma in the rituximab eraClémentine Sarkozy, Bertrand Coiffier
Expert Opinion on Investigational Drugs|April 24, 2020
Novel agents for mantle cell lymphoma: molecular rational and clinical dataClémentine Sarkozy, Vincent Ribrag
Hematology. American Society of Hematology. Education Program|December 4, 2016
Diffuse large B-cell lymphoma: R-CHOP failure-what to do?Bertrand Coiffier, Clémentine Sarkozy
Hematology. American Society of Hematology. Education Program|December 5, 2025
All shades of gray in the mediastinum: do we have bright ideas about how to diagnose and treat mediastinal gray zone lymphoma in the era of targeted agents?Clémentine Sarkozy, Alexandra Traverse-Glehen
Best Practice & Research. Clinical Haematology|September 15, 2018
Management of relapsed/refractory DLBCLClémentine Sarkozy, Laurie H Sehn
Expert Review of Hematology|January 15, 2015
Chemotherapy-free treatment in patients with follicular lymphomaClémentine Sarkozy, Gilles Salles, Emmanuel Bachy
Current Oncology Reports|May 25, 2015
The biology of aging and lymphoma: a complex interplayClémentine Sarkozy, Gilles Salles, Claire Falandry
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Expert Review of Hematology|November 14, 2013
Treatment approaches to asymptomatic follicular lymphomaClémentine Sarkozy, Gilles Salles
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2013
Diffuse large B-cell lymphoma in the elderly: a review of potential difficultiesClémentine Sarkozy, Bertrand Coiffier
Presse Medicale (Paris, France : 1983)|August 27, 2019
Clémentine Sarkozy, Gilles Salles
Current Opinion in Oncology|August 11, 2015
Primary refractory diffuse large B cell lymphoma in the rituximab eraClémentine Sarkozy, Bertrand Coiffier
Expert Opinion on Investigational Drugs|April 24, 2020
Novel agents for mantle cell lymphoma: molecular rational and clinical dataClémentine Sarkozy, Vincent Ribrag
Hematology. American Society of Hematology. Education Program|December 4, 2016
Diffuse large B-cell lymphoma: R-CHOP failure-what to do?Bertrand Coiffier, Clémentine Sarkozy
Hematology. American Society of Hematology. Education Program|December 5, 2025
All shades of gray in the mediastinum: do we have bright ideas about how to diagnose and treat mediastinal gray zone lymphoma in the era of targeted agents?Clémentine Sarkozy, Alexandra Traverse-Glehen
Best Practice & Research. Clinical Haematology|September 15, 2018
Management of relapsed/refractory DLBCLClémentine Sarkozy, Laurie H Sehn
Expert Review of Hematology|January 15, 2015
Chemotherapy-free treatment in patients with follicular lymphomaClémentine Sarkozy, Gilles Salles, Emmanuel Bachy
Current Oncology Reports|May 25, 2015
The biology of aging and lymphoma: a complex interplayClémentine Sarkozy, Gilles Salles, Claire Falandry
Pageof 7